Medical Devices - New Zealand

  • New Zealand
  • The projected revenue in the Medical Devices market market in New Zealand is expected to reach US$1,158.00m in 2024.
  • Among the various markets, Cardiology_Devices is the largest, with a projected market volume of US$170.20m in 2024.
  • The market is expected to grow at an annual growth rate of 6.33% from 2024 to 2029, resulting in a market volume of US$1,574.00m by 2029.
  • When compared globally, the United States is projected to generate the highest revenue of US$179.80bn in 2024.
  • New Zealand's medical device market is experiencing a surge in demand for innovative technologies, driven by the country's strong focus on healthcare advancements and patient-centric care.

Key regions: Spain, Japan, United States, Europe, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Devices market in New Zealand is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Medical Devices market in New Zealand are driven by a desire for advanced technology and innovative solutions. Consumers in New Zealand value medical devices that are user-friendly, efficient, and provide accurate results. They are also increasingly seeking devices that are portable and can be used at home, allowing for greater convenience and independence in managing their health. As a result, there is a growing demand for wearable medical devices and home monitoring systems in the country. Trends in the market are also contributing to the development of the Medical Devices market in New Zealand. One key trend is the increasing focus on preventive healthcare and early detection of diseases. This has led to a rising demand for diagnostic devices, such as imaging equipment and laboratory instruments, which enable healthcare professionals to identify and treat medical conditions at an early stage. Another trend is the growing adoption of telemedicine, which allows patients to consult with healthcare providers remotely using digital devices. This trend has been accelerated by the COVID-19 pandemic and the need for social distancing measures. Local special circumstances in New Zealand further support the growth of the Medical Devices market. The country has a well-established healthcare system that provides universal access to healthcare services. This ensures a consistent demand for medical devices across the population. Additionally, New Zealand has a strong regulatory framework for medical devices, which ensures the safety and effectiveness of products in the market. This gives consumers confidence in the quality of medical devices available in the country. Underlying macroeconomic factors also play a role in the development of the Medical Devices market in New Zealand. The country has a stable economy with a high standard of living, which enables individuals to afford and access medical devices. Furthermore, the government of New Zealand has been investing in healthcare infrastructure and technology to improve the delivery of healthcare services. This includes the development of digital health initiatives and the expansion of telehealth services, which create opportunities for the Medical Devices market. In conclusion, the Medical Devices market in New Zealand is growing due to customer preferences for advanced technology and innovative solutions, trends in the market such as preventive healthcare and telemedicine, local special circumstances including a well-established healthcare system and strong regulatory framework, and underlying macroeconomic factors such as a stable economy and government investment in healthcare infrastructure. These factors are driving the demand for medical devices in New Zealand and creating opportunities for market growth.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)